Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer

Clinical trial NCT00544063 · UNKNOWN

Trial details

NCT number: NCT00544063
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2006-10-01
Primary completion: 2011-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.